BeiGene Historical Balance Sheet

BGNE Stock

USD 218.97 6.58 3.10%

Trend analysis of BeiGene balance sheet accounts such as Short Long Term Debt Total of 976.7 M, Other Current Liabilities of 823.6 M or Total Current Liabilities of 1.9 B provides information on BeiGene's total assets, liabilities, and equity, which is the actual value of BeiGene to its prevalent stockholders. By breaking down trends over time using BeiGene balance sheet statements, investors will see what precisely the company owns and what it owes to creditors or other parties at the end of each accounting year.

Cash Flow Balance Sheet Income Statement

Yuan Drop

Covid

Financial Statement Analysis is much more than just reviewing and examining BeiGene latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether BeiGene is a good buy for the upcoming year.

BeiGene Inventory

436.93 Million

Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in BeiGene. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.

For information on how to trade BeiGene Stock refer to our How to Trade BeiGene Stock guide.

About BeiGene Balance Sheet Analysis

Balance Sheet is a snapshot of the financial position of BeiGene at a specified time, usually calculated after every quarter, six months, or one year. BeiGene Balance Sheet has two main parts: assets and liabilities. Liabilities are the debts or obligations of BeiGene and are divided into current liabilities and long term liabilities. An asset, on the other hand, is anything of value that can be converted into cash and which BeiGene currently owns. An asset can also be divided into two categories, current and non-current.

BeiGene Balance Sheet Chart

At present, BeiGene's Other Current Liabilities is projected to increase significantly based on the last few years of reporting. The current year's Total Current Liabilities is expected to grow to about 1.9 B, whereas Total Stockholder Equity is forecasted to decline to about 2.2 B.

Total Assets Short Long Term Debt Total Other Current Liab Total Current Liabilities Common Stock Shares Outstanding Other Current Assets

Add Fundamental

Total Assets

Total assets refers to the total amount of BeiGene assets owned. Assets are items that have some economic value and are expended over time to create a benefit for the owner. These assets are usually recorded in BeiGene books under different categories such as cash, marketable securities, accounts receivable,prepaid expenses, inventory, fixed assets, intangible assets, other assets, marketable securities, accounts receivable, prepaid expenses and others. The total value of all owned resources that are expected to provide future economic benefits to the business, including cash, investments, accounts receivable, inventory, property, plant, equipment, and intangible assets.

Total Current Liabilities

Total Current Liabilities is an item on BeiGene balance sheet that include short term debt, accounts payable, accrued salaries payable, payroll taxes payable, accrued liabilities and other debts. Total Current Liabilities of BeiGene are important to investors because some useful performance ratios such as Current Ratio and Quick Ratio require Total Current Liabilities to be accurate. The total amount of liabilities that a company is expected to pay within one year, including debts, accounts payable, and other short-term financial obligations.

Common Stock Shares Outstanding

The total number of shares of a company's common stock that are currently owned by all its shareholders.

Other Current Assets

Assets expected to be converted into cash, sold, or consumed either in one year or in the operating cycle, which are not included under standard current asset categories.

Most accounts from BeiGene's balance sheet are interrelated and interconnected. However, analyzing balance sheet accounts one by one will only give a small insight into BeiGene current financial condition. On the other hand, looking into the entire matrix of balance sheet accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in BeiGene. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.

For information on how to trade BeiGene Stock refer to our How to Trade BeiGene Stock guide.At present, BeiGene's Other Current Liabilities is projected to increase significantly based on the last few years of reporting. The current year's Total Current Liabilities is expected to grow to about 1.9 B, whereas Total Stockholder Equity is forecasted to decline to about 2.2 B.

	2021	2022	2023	2024 (projected)
Short and Long Term Debt Total	694.6M	891.1M	930.2M	976.7M
Total Assets	8.6B	6.4B	5.8B	3.2B

Short Long Term Debt Total Total Assets

BeiGene balance sheet Correlations

	Total Assets	Short Long Term Debt Total	Other Current Liab	Total Current Liabilities	Total Stockholder Equity	Other Liab	Net Tangible Assets	Property Plant And Equipment Net	Current Deferred Revenue	Net Debt	Retained Earnings	Accounts Payable	Cash	Non Current Assets Total	Non Currrent Assets Other	Other Assets	Long Term Debt	Cash And Short Term Investments	Common Stock Total Equity	Common Stock Shares Outstanding	Short Term Investments	Non Current Liabilities Total	Other Current Assets	Other Stockholder Equity	Total Liab	Property Plant And Equipment Gross
Total Assets		0.86	0.61	0.85	1.0	0.95	0.94	0.71	0.68	-0.92	-0.82	0.88	0.92	0.77	-0.3	0.65	0.77	0.99	0.87	0.9	0.65	0.94	0.93	0.9	0.92	0.71
Short Long Term Debt Total	0.86		0.84	0.96	0.83	0.86	0.95	0.96	0.41	-0.89	-0.99	0.99	0.94	0.96	-0.45	0.32	0.73	0.8	0.96	0.89	0.32	0.83	0.96	0.99	0.97	0.96
Other Current Liab	0.61	0.84		0.92	0.58	0.7	0.82	0.94	0.1	-0.71	-0.85	0.82	0.77	0.95	-0.05	0.29	0.52	0.54	0.81	0.64	0.05	0.45	0.82	0.82	0.82	0.92
Total Current Liabilities	0.85	0.96	0.92		0.83	0.91	0.97	0.95	0.38	-0.88	-0.95	0.96	0.92	0.98	-0.22	0.42	0.65	0.8	0.93	0.84	0.36	0.73	0.95	0.97	0.97	0.94
Total Stockholder Equity	1.0	0.83	0.58	0.83		0.95	0.93	0.68	0.7	-0.92	-0.79	0.87	0.91	0.74	-0.28	0.68	0.76	0.99	0.85	0.88	0.68	0.94	0.92	0.89	0.91	0.68
Other Liab	0.95	0.86	0.7	0.91	0.95		0.96	0.75	0.64	-0.87	-0.82	0.89	0.89	0.81	-0.14	0.63	0.68	0.95	0.87	0.84	0.69	0.86	0.92	0.9	0.94	0.73
Net Tangible Assets	0.94	0.95	0.82	0.97	0.93	0.96		0.88	0.52	-0.94	-0.93	0.96	0.96	0.92	-0.27	0.55	0.73	0.92	0.95	0.88	0.5	0.86	0.99	0.98	0.99	0.87
Property Plant And Equipment Net	0.71	0.96	0.94	0.95	0.68	0.75	0.88		0.2	-0.8	-0.97	0.93	0.87	0.99	-0.36	0.19	0.62	0.64	0.91	0.79	0.1	0.64	0.89	0.93	0.91	1.0
Current Deferred Revenue	0.68	0.41	0.1	0.38	0.7	0.64	0.52	0.2		-0.51	-0.36	0.48	0.49	0.29	-0.13	0.58	0.66	0.73	0.48	0.54	0.74	0.76	0.54	0.47	0.51	0.2
Net Debt	-0.92	-0.89	-0.71	-0.88	-0.92	-0.87	-0.94	-0.8	-0.51		0.88	-0.88	-0.99	-0.83	0.44	-0.67	-0.65	-0.89	-0.85	-0.87	-0.37	-0.87	-0.94	-0.94	-0.92	-0.82
Retained Earnings	-0.82	-0.99	-0.85	-0.95	-0.79	-0.82	-0.93	-0.97	-0.36	0.88		-0.97	-0.93	-0.96	0.49	-0.28	-0.68	-0.76	-0.93	-0.88	-0.22	-0.78	-0.94	-0.98	-0.95	-0.98
Accounts Payable	0.88	0.99	0.82	0.96	0.87	0.89	0.96	0.93	0.48	-0.88	-0.97		0.93	0.95	-0.38	0.35	0.8	0.84	0.98	0.88	0.41	0.86	0.98	0.99	0.98	0.93
Cash	0.92	0.94	0.77	0.92	0.91	0.89	0.96	0.87	0.49	-0.99	-0.93	0.93		0.89	-0.45	0.59	0.68	0.88	0.9	0.88	0.35	0.87	0.97	0.97	0.96	0.88
Non Current Assets Total	0.77	0.96	0.95	0.98	0.74	0.81	0.92	0.99	0.29	-0.83	-0.96	0.95	0.89		-0.27	0.29	0.67	0.7	0.93	0.8	0.21	0.67	0.93	0.95	0.94	0.98
Non Currrent Assets Other	-0.3	-0.45	-0.05	-0.22	-0.28	-0.14	-0.27	-0.36	-0.13	0.44	0.49	-0.38	-0.45	-0.27		0.11	-0.2	-0.25	-0.3	-0.49	0.18	-0.49	-0.31	-0.42	-0.32	-0.43
Other Assets	0.65	0.32	0.29	0.42	0.68	0.63	0.55	0.19	0.58	-0.67	-0.28	0.35	0.59	0.29	0.11		0.32	0.69	0.34	0.41	0.5	0.52	0.53	0.43	0.48	0.2
Long Term Debt	0.77	0.73	0.52	0.65	0.76	0.68	0.73	0.62	0.66	-0.65	-0.68	0.8	0.68	0.67	-0.2	0.32		0.74	0.83	0.7	0.51	0.82	0.8	0.73	0.72	0.6
Cash And Short Term Investments	0.99	0.8	0.54	0.8	0.99	0.95	0.92	0.64	0.73	-0.89	-0.76	0.84	0.88	0.7	-0.25	0.69	0.74		0.83	0.85	0.74	0.94	0.89	0.86	0.89	0.63
Common Stock Total Equity	0.87	0.96	0.81	0.93	0.85	0.87	0.95	0.91	0.48	-0.85	-0.93	0.98	0.9	0.93	-0.3	0.34	0.83	0.83		0.83	0.43	0.83	0.96	0.96	0.96	0.89
Common Stock Shares Outstanding	0.9	0.89	0.64	0.84	0.88	0.84	0.88	0.79	0.54	-0.87	-0.88	0.88	0.88	0.8	-0.49	0.41	0.7	0.85	0.83		0.42	0.87	0.87	0.9	0.88	0.8
Short Term Investments	0.65	0.32	0.05	0.36	0.68	0.69	0.5	0.1	0.74	-0.37	-0.22	0.41	0.35	0.21	0.18	0.5	0.51	0.74	0.43	0.42		0.63	0.45	0.38	0.46	0.07
Non Current Liabilities Total	0.94	0.83	0.45	0.73	0.94	0.86	0.86	0.64	0.76	-0.87	-0.78	0.86	0.87	0.67	-0.49	0.52	0.82	0.94	0.83	0.87	0.63		0.87	0.86	0.85	0.65
Other Current Assets	0.93	0.96	0.82	0.95	0.92	0.92	0.99	0.89	0.54	-0.94	-0.94	0.98	0.97	0.93	-0.31	0.53	0.8	0.89	0.96	0.87	0.45	0.87		0.98	0.98	0.89
Other Stockholder Equity	0.9	0.99	0.82	0.97	0.89	0.9	0.98	0.93	0.47	-0.94	-0.98	0.99	0.97	0.95	-0.42	0.43	0.73	0.86	0.96	0.9	0.38	0.86	0.98		0.99	0.94
Total Liab	0.92	0.97	0.82	0.97	0.91	0.94	0.99	0.91	0.51	-0.92	-0.95	0.98	0.96	0.94	-0.32	0.48	0.72	0.89	0.96	0.88	0.46	0.85	0.98	0.99		0.9
Property Plant And Equipment Gross	0.71	0.96	0.92	0.94	0.68	0.73	0.87	1.0	0.2	-0.82	-0.98	0.93	0.88	0.98	-0.43	0.2	0.6	0.63	0.89	0.8	0.07	0.65	0.89	0.94	0.9

Click cells to compare fundamentals

BeiGene Account Relationship Matchups

BeiGene balance sheet Accounts

	2019	2020	2021	2022	2023	2024 (projected)
Total Assets	1.6B	5.6B	8.6B	6.4B	5.8B	3.2B
Short Long Term Debt Total	277.3M	562.0M	694.6M	891.1M	930.2M	976.7M
Other Current Liab	152.7M	127.8M	480.0M	114.3M	784.4M	823.6M
Total Current Liabilities	286.0M	1.1B	1.6B	1.0B	1.8B	1.9B
Total Stockholder Equity	978.4M	3.9B	6.2B	4.4B	3.5B	2.2B
Other Liab	57.1M	443.3M	562.5M	283.7M	326.3M	342.6M
Net Tangible Assets	956.3M	3.9B	6.2B	4.3B	5.0B	5.2B
Property Plant And Equipment Net	313.1M	446.3M	686.7M	845.9M	1.4B	1.5B
Net Debt	(340.7M)	(820.0M)	(3.7B)	(3.0B)	(2.3B)	(2.1B)
Retained Earnings	(2.0B)	(3.6B)	(5.0B)	(7.1B)	(8.0B)	(7.6B)
Accounts Payable	122.5M	232.0M	262.4M	294.8M	315.1M	330.9M
Cash	618.0M	1.4B	4.4B	3.9B	3.2B	3.3B
Non Current Assets Total	439.6M	640.1M	1.0B	845.9M	1.6B	1.7B
Non Currrent Assets Other	2.5M	24.6M	30.7M	(186.5M)	(18.7M)	(17.8M)
Other Assets	108.7M	186.8M	8.6B	819.9M	2.0	1.9
Long Term Debt	240.7M	183.6M	202.1M	209.1M	197.6M	143.1M
Cash And Short Term Investments	985.5M	4.7B	6.6B	4.5B	3.2B	2.3B
Common Stock Total Equity	77K	79K	118K	133K	153.0K	160.6K
Common Stock Shares Outstanding	60.1M	83.5M	92.8M	103.1M	104.4M	72.1M
Short Term Investments	364.7M	3.3B	2.2B	665.3M	2.6M	2.5M
Liabilities And Stockholders Equity	1.6B	5.6B	8.6B	6.4B	5.8B	3.2B
Non Current Liabilities Total	347.9M	656.3M	803.4M	977.9M	423.6M	372.9M
Other Current Assets	85.8M	133.0M	246.2M	190.9M	205.5M	215.8M
Other Stockholder Equity	2.9B	7.4B	11.2B	11.5B	11.6B	12.2B
Total Liab	633.9M	1.7B	2.4B	2.0B	2.2B	2.3B
Property Plant And Equipment Gross	324.9M	399.5M	811.0M	1.1B	1.6B	1.7B
Total Current Assets	1.2B	5.0B	7.6B	4.7B	4.2B	2.6B
Accumulated Other Comprehensive Income	(8.0M)	6.9M	18.0M	(77.4M)	(99.4M)	(94.5M)
Short Term Debt	10.8M	348.9M	449.5M	353.0M	710.3M	745.8M
Common Stock	79K	118K	133K	135K	155.3K	83.2K
Property Plant Equipment	324.9M	357.7M	587.6M	955.9M	1.1B	1.2B
Deferred Long Term Liab	11.1M	10.5M	10.8M	14.2M	16.3M	10.1M
Long Term Debt Total	189.7M	240.7M	183.6M	202.1M	232.4M	156.4M
Capital Surpluse	2.7B	2.9B	7.4B	11.2B	12.9B	13.5B
Net Receivables	72.8M	79.7M	500.2M	173.2M	395.9M	415.7M
Retained Earnings Total Equity	(1.0B)	(2.0B)	(3.6B)	(5.0B)	(4.5B)	(4.2B)
Inventory	28.6M	89.3M	242.6M	282.3M	416.1M	436.9M

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

MSFT	Microsoft
F	Ford Motor
CRM	Salesforce

When determining whether BeiGene is a strong investment it is important to analyze BeiGene's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact BeiGene's future performance. For an informed investment choice regarding BeiGene Stock, refer to the following important reports:

How To Invest In BeiGene

Details

Is BeiGene Stock a good investment?

Details

What is BeiGene's Net Worth?

Details

Largest Biotechnology Companies

View

Largest Pharmaceuticals, Biotechnology & Life Sciences Companies

View

For information on how to trade BeiGene Stock refer to our How to Trade BeiGene Stock guide.

You can also try the Price Transformation module to use Price Transformation models to analyze the depth of different equity instruments across global markets.

Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of BeiGene. If investors know BeiGene will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about BeiGene listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.

Earnings Share

(4.95)

Revenue Per Share

29.652

Quarterly Revenue Growth

0.561

Return On Assets

(0.1)

Return On Equity

(0.15)

The market value of BeiGene is measured differently than its book value, which is the value of BeiGene that is recorded on the company's balance sheet. Investors also form their own opinion of BeiGene's value that differs from its market value or its book value, called intrinsic value, which is BeiGene's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because BeiGene's market value can be influenced by many factors that don't directly affect BeiGene's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.

Please note, there is a significant difference between BeiGene's value and its price as these two are different measures arrived at by different means. Investors typically determine if BeiGene is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, BeiGene's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

BeiGene Historical Balance Sheet

BeiGene Inventory

436.93 Million

About BeiGene Balance Sheet Analysis

BeiGene Balance Sheet Chart

Total Assets

Total Current Liabilities

Common Stock Shares Outstanding

Other Current Assets

BeiGene balance sheet Correlations

BeiGene Account Relationship Matchups

High Positive Relationship

High Negative Relationship

BeiGene balance sheet Accounts

Also Currently Popular

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Total Stockholder Equity	+ 1.0	Total Assets
Property Plant And Equipment Gross	+ 1.0	Property Plant And Equipment Net
Cash And Short Term Investments	+ 0.99	Total Assets
Accounts Payable	+ 0.99	Short Long Term Debt Total
Other Stockholder Equity	+ 0.99	Short Long Term Debt Total
Cash And Short Term Investments	+ 0.99	Total Stockholder Equity

Cash	- 0.99	Net Debt
Retained Earnings	- 0.99	Short Long Term Debt Total
Property Plant And Equipment Gross	- 0.98	Retained Earnings
Other Stockholder Equity	- 0.98	Retained Earnings
Accounts Payable	- 0.97	Retained Earnings
Retained Earnings	- 0.97	Property Plant And Equipment Net